1-2 of 2
Marie-Alix Poul
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3

Free
Christophe Le Clorennec, Hervé Bazin, Olivier Dubreuil, Christel Larbouret, Charline Ogier, Yassamine Lazrek, Véronique Garambois, Marie-Alix Poul, Philippe Mondon, Jean-Marc Barret, Gérard Mathis, Jean-François Prost, André Pèlegrin, Thierry Chardès
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1312–1323.
https://doi.org/10.1158/1535-7163.MCT-16-0886
Published: 04 July 2017
View articletitled, Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3
Open the PDF for Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3 in another window
Includes: Supplementary data
Journal Articles

Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5

Free
Marianne Le Gall, Ronan Crépin, Madeline Neiveyans, Christian Auclair, Yongfeng Fan, Yu Zhou, James D. Marks, André Pèlegrin, Marie-Alix Poul
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (11): 2595–2605.
https://doi.org/10.1158/1535-7163.MCT-15-0321
Published: 03 November 2015
View articletitled, Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5
Open the PDF for Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5 in another window
Includes: Supplementary data